Psychiatry & Neurology Doctors in Woodinville, WA Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Steven Paul Jewitt, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 16326 197th Ave Ne, Woodinville, WA 98077 Phone: 360-794-3270    Fax: 360-794-3225

Jon Eric Berner, Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 18500 156th Ave Ne, Ste 201 Jon Berner Md Phd, Woodinville, WA 98072 Phone: 425-481-0429    Fax: 425-483-0660

Linda L Williams, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 14809 210th Ave Ne, Woodinville, WA 98077 Phone: 425-882-8570    Fax: 425-882-8590

News Archive

Quantifying the quality of health aid

In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant in global health policy at CGD, describe a paper they wrote in which they try to determine "which donor provides the 'best' health aid, and why this is a relevant question."

Internal Medicine 2012 to take place from April 19 - 21 in New Orleans

More than 5,000 internal medicine physicians, or internists, subspecialists, medical students, and allied health professionals will meet in New Orleans for Internal Medicine 2012, the annual scientific meeting of the American College of Physicians (ACP), April 19 - 21 (Thursday - Saturday), at the Ernest N. Morial Convention Center. Internists specialize in the prevention, detection, and treatment of illnesses in adults.

Two genetic studies expand list of genes connected to major Western health problems

Two recent genetic studies expand the list of genes involved with body fat and body mass index, and their connection to major Western health problems: heart disease, high blood pressure and diabetes. One study showed that higher body mass index (BMI) caused harmful effects on the risk of type 2 diabetes, high blood pressure and inflammation, while another study found gene signals linked to higher levels of body fat metrics, without showing causality.

Akebia commences dosing in AKB-9778 Phase 1 study for diabetic macular edema and retinopathy

Akebia Therapeutics, Inc., a small molecule discovery and development company focused on anemia and vascular disorders, today announced that it has dosed the first subjects in a first-in-man Phase 1 study of AKB-9778, a first-in-class human protein tyrosine phosphatase beta (HPTPβ) inhibitor in development for diabetic macular edema (DME) and diabetic retinopathy (DR).

Read more Medical News

› Verified 2 days ago